In this podcast, expert clinicians will discuss new evidence on investigational agents, the anti-integrin and S1P-1 receptor modulators, that are in late-stage development for treating moderate to severe CD.
Podchaser is the ultimate destination for podcast data, search, and discovery. Learn More